Related Experiment Video
Updated: May 9, 2026
Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
Published on: September 30, 2016
Effect of c-Met inhibitor SU11274 on human colon cancer cell growth
Shuo-hui Gao1, Chao Liu, Jun Wei
1Department of General Surgery, the Third Hospital of Jilin University, Changchun, Jilin, China.
Background:
Colon cancer is one of the major malignancies worldwide and it still remains resistant to much of the currently available chemotherapy. Downregulation of HGF/c-Met signaling pathway is an emerging therapy for cancer treatment.
Methods:
In this study, the inhibitory effects of c-Met phosphorylation were observed with SU11274 on different colon cancer cell lines in vitro.
Results:
The results revealed the significant inhibitory effects of SU11274 on cell proliferation and cell survival, in a time and dose-dependent manner. Furthermore, the inhibitory effects of SU11274 on different subgroups of colon cancer cells via the HGF/c-Met signaling pathway were implicated in this study.
Conclusion:
The results suggested the possible selective therapeutic effects of c-Met inhibitor on colon cancer.
Insights
This study investigated SU11274, a c-Met inhibitor, showing its effectiveness in reducing colon cancer cell growth and survival. Results suggest c-Met inhibitors may offer selective therapeutic benefits for colon cancer treatment.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Colon cancer is a leading global malignancy with limited chemotherapy options.
- Targeting the HGF/c-Met signaling pathway presents a novel therapeutic strategy for cancer treatment.
Purpose of the Study:
- To evaluate the inhibitory effects of SU11274 on colon cancer cell lines.
- To investigate the role of the HGF/c-Met signaling pathway in colon cancer treatment.
Main Methods:
- In vitro experiments were conducted using various colon cancer cell lines.
- The effects of SU11274 on c-Met phosphorylation were analyzed.
Main Results:
- SU11274 demonstrated significant inhibition of colon cancer cell proliferation and survival.
- These inhibitory effects were observed in a time- and dose-dependent manner.
- The study implicated SU11274's action on colon cancer cells through the HGF/c-Met pathway.
Conclusions:
- The c-Met inhibitor SU11274 shows potential for selective therapeutic effects in colon cancer.
- Further research into c-Met inhibitors could lead to improved colon cancer treatments.
